Zdrowie i gospodarka · 25/04/2022
FDA Classifies Autofluorescence Detection Device for General Surgery and Dermatological Use into Class II with Special Controls
The FDA has classified the autofluorescence detection device for general surgery and dermatological use into Class II with special controls, aiming to ensure the device's safety and effectiveness while enhancing patients' access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →